Bausch Health Cos Price to Sales Ratio 2012-2025 | BHC
Historical PS ratio values for Bausch Health Cos (BHC) over the last 10 years. The current P/S ratio for Bausch Health Cos as of April 14, 2026 is .
| Bausch Health Cos P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-04-15 | 5.74 | 0.21 | |
| 2025-12-31 | 6.95 | $27.49 | 0.25 |
| 2025-09-30 | 6.45 | $26.99 | 0.24 |
| 2025-06-30 | 6.66 | $26.66 | 0.25 |
| 2025-03-31 | 6.47 | $26.37 | 0.25 |
| 2024-12-31 | 8.06 | $26.13 | 0.31 |
| 2024-09-30 | 8.16 | $25.77 | 0.32 |
| 2024-06-30 | 6.97 | $25.08 | 0.28 |
| 2024-03-31 | 10.61 | $24.50 | 0.43 |
| 2023-12-31 | 8.02 | $23.98 | 0.33 |
| 2023-09-30 | 8.22 | $23.44 | 0.35 |
| 2023-06-30 | 8.00 | $22.94 | 0.35 |
| 2023-03-31 | 8.10 | $22.47 | 0.36 |
| 2022-12-31 | 6.28 | $22.43 | 0.28 |
| 2022-09-30 | 6.89 | $22.50 | 0.31 |
| 2022-06-30 | 8.36 | $22.66 | 0.37 |
| 2022-03-31 | 22.85 | $23.08 | 0.99 |
| 2021-12-31 | 27.61 | $23.45 | 1.18 |
| 2021-09-30 | 27.85 | $23.56 | 1.18 |
| 2021-06-30 | 29.32 | $23.74 | 1.24 |
| 2021-03-31 | 31.74 | $22.57 | 1.41 |
| 2020-12-31 | 20.80 | $22.59 | 0.92 |
| 2020-09-30 | 15.54 | $22.67 | 0.69 |
| 2020-06-30 | 18.29 | $22.96 | 0.80 |
| 2020-03-31 | 15.50 | $24.39 | 0.64 |
| 2019-12-31 | 29.92 | $24.44 | 1.22 |
| 2019-09-30 | 21.85 | $24.16 | 0.90 |
| 2019-06-30 | 25.22 | $23.96 | 1.05 |
| 2019-03-31 | 24.70 | $23.91 | 1.03 |
| 2018-12-31 | 18.47 | $23.86 | 0.77 |
| 2018-09-30 | 25.67 | $23.97 | 1.07 |
| 2018-06-30 | 23.24 | $24.19 | 0.96 |
| 2018-03-31 | 15.92 | $24.51 | 0.65 |
| 2017-12-31 | 20.78 | $24.85 | 0.84 |
| 2017-09-30 | 14.33 | $25.62 | 0.56 |
| 2017-06-30 | 17.30 | $26.42 | 0.65 |
| 2017-03-31 | 11.03 | $27.05 | 0.41 |
| 2016-12-31 | 14.52 | $27.90 | 0.52 |
| 2016-09-30 | 24.55 | $29.03 | 0.85 |
| 2016-06-30 | 20.14 | $29.88 | 0.67 |
| 2016-03-31 | 26.30 | $30.80 | 0.85 |
| 2015-12-31 | 101.65 | $30.24 | 3.36 |
| 2015-09-30 | 178.38 | $28.70 | 6.22 |
| 2015-06-30 | 222.15 | $26.79 | 8.29 |
| 2015-03-31 | 198.62 | $24.83 | 8.00 |
| 2014-12-31 | 143.11 | $24.15 | 5.93 |
| 2014-09-30 | 131.20 | $24.07 | 5.45 |
| 2014-06-30 | 126.12 | $22.66 | 5.56 |
| 2014-03-31 | 131.83 | $20.17 | 6.54 |
| 2013-12-31 | 117.40 | $18.03 | 6.51 |
| 2013-09-30 | 104.33 | $14.61 | 7.14 |
| 2013-06-30 | 86.08 | $12.83 | 6.71 |
| 2013-03-31 | 75.02 | $12.03 | 6.23 |
| 2012-12-31 | 59.77 | $11.32 | 5.28 |
| 2012-09-30 | 55.27 | $10.31 | 5.36 |
| 2012-06-30 | 44.79 | $9.33 | 4.80 |
| 2012-03-31 | 53.69 | $8.48 | 6.33 |
| 2011-12-31 | 46.69 | $7.40 | 6.31 |
| 2011-09-30 | 37.12 | $8.02 | 4.63 |
| 2011-06-30 | 51.96 | $7.44 | 6.98 |
| 2011-03-31 | 49.81 | $7.08 | 7.03 |
| 2010-12-31 | 28.29 | $6.77 | 4.18 |
| 2010-09-30 | 24.08 | $5.67 | 4.25 |
| 2010-06-30 | 18.42 | $5.73 | 3.22 |
| 2010-03-31 | 15.96 | $5.47 | 2.92 |
| 2009-12-31 | 13.20 | $5.18 | 2.55 |
| 2009-09-30 | 14.50 | $4.80 | 3.02 |
| 2009-06-30 | 12.55 | $4.60 | 2.73 |
| 2009-03-31 | 10.14 | $4.54 | 2.23 |
| 2008-12-31 | 8.45 | $4.74 | 1.78 |
| 2008-09-30 | 8.38 | $4.86 | 1.72 |
| 2008-06-30 | 7.98 | $4.89 | 1.63 |
| 2008-03-31 | 8.55 | $4.99 | 1.71 |
| 2007-12-31 | 10.46 | $5.24 | 2.00 |
| 2007-09-30 | 13.21 | $5.89 | 2.24 |
| 2007-06-30 | 18.89 | $6.53 | 2.89 |
| 2007-03-31 | 16.01 | $6.84 | 2.34 |
| 2006-12-31 | 14.88 | $6.69 | 2.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |